Voyager Therapeutics's Total Assets for the quarter that ended in Mar. 2024 was $469.6 Mil.
During the past 12 months, Voyager Therapeutics's average Total Assets Growth Rate was 11.20% per year.
During the past 3 years, the average Total Assets Growth Rate was 14.40% per year.
During the past 5 years, the average Total Assets Growth Rate was 20.90% per year.
During the past 10 years, the average Total Assets Growth Rate was 73.60% per year.
During the past 11 years, Voyager Therapeutics's highest 3-Year average Total Assets Growth Rate was 926.60%. The lowest was -17.90%. And the median was 46.80%.
The historical data trend for Voyager Therapeutics's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Voyager Therapeutics's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Voyager Therapeutics (NAS:VYGR) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Voyager Therapeutics's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Voyager Therapeutics Total Assets Related Terms
Thank you for viewing the detailed overview of Voyager Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Voyager Therapeutics (Voyager Therapeutics) Business Description
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. The company operates in a single segment of developing and commercializing gene therapies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VYGR has been successfully added to your 